3 drug(s) with this reaction
2,443 total reports
Intentional Product Misuse has been reported as an adverse reaction across 3 drug(s) manufactured by Amgen Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 2,443 adverse event reports mention intentional product misuse in connection with Amgen Inc products.
This page provides a breakdown of which Amgen Inc drugs are most commonly associated with intentional product misuse, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Amgen Inc drugs have intentional product misuse listed in their FDA adverse event reports, sorted by report count:
In addition to intentional product misuse, the following adverse reactions have been reported across Amgen Inc's drug portfolio:
3 drug(s) manufactured by Amgen Inc have intentional product misuse listed in their FDA adverse event reports: CINACALCET HYDROCHLORIDE, DARBEPOETIN ALFA, ROMIPLOSTIM.
There are a combined 2,443 reports of intentional product misuse across 3 Amgen Inc drug(s) in the FDA adverse event database.